Enzyme

Neochromosome Announces Collaboration with University of Edinburgh Creating Defined Variant Libraries for Designer Enzymes

Retrieved on: 
Thursday, December 14, 2023

Creating improved engineering processes for designer enzymes could lead to safer and more effective therapeutics, such as enzyme replacement therapy, for a broad range of genetic diseases.

Key Points: 
  • Creating improved engineering processes for designer enzymes could lead to safer and more effective therapeutics, such as enzyme replacement therapy, for a broad range of genetic diseases.
  • To overcome this challenge, scientists use computational and experimental techniques to create libraries of thousands of ‘designer’ synthetically created enzymes.
  • Therefore, there is an urgent need to establish new methods of reliably creating designer enzymes on demand,” said Dr. Leslie Mitchell, Co-founder and CEO of Neochromosome.
  • From defined variant libraries and variant mining to clonal selection and DNA repository, Neochromosome works with its partners through an iterative, customized process to ensure high-quality deliverables with fast turnaround times.

Glycomics Market Size, Share & Trends Analysis Report 2023: Enzymes, Kits, Reagents, Instruments, Drug Discovery & Development, Diagnostics - Global Market to Reach $4.92 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023

Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market.

Key Points: 
  • Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market.
  • Moreover, the increasing demand for personalized medicine has further supported industry growth as glycomics plays a significant role in developing glycan-based diagnostic solutions.
  • Recently glycomics have shown promise in identifying disease-specific glycan biomarkers for early detection and diagnosis of various health conditions.
  • For instance, in November 2021 GlycoPath Inc. launched its glycan imaging kit for glycoproteomic analysis of clinical and research samples.

Rising Demand for Pet and Farm Animal Health Products Propels Global Animal Therapeutics & Diagnostics Market to $81.2 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, November 27, 2023

The global animal therapeutics & diagnostics market is expected to witness stable growth during the forecast period.

Key Points: 
  • The global animal therapeutics & diagnostics market is expected to witness stable growth during the forecast period.
  • There continues to be widespread demand for poultry products worldwide, with the United States at the forefront of demand.
  • The pet and farm animal sectors of the animal health business are expanding and provide goods and services to billions of people globally.
  • The report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market.

Enveric Biosciences Announces Presentation of Two Posters at Canadian Chemical Engineering Conference (CSChE 2023)

Retrieved on: 
Friday, November 24, 2023

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced the presentation of two posters at the Canadian Chemical Engineering Conference (CSChE 2023) which was held October 29th to November 1, 2023.

Key Points: 
  • Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced the presentation of two posters at the Canadian Chemical Engineering Conference (CSChE 2023) which was held October 29th to November 1, 2023.
  • First, the Enveric research team achieved the production of milligram quantities of pure compounds in small-scale batch fermentations.
  • The purified transamination products were converted to methamphetamine derivatives, including MDMA, by chemical reduction and N-methylation.
  • Using the synthetic biology platform, Enveric researchers were able to produce several previously undescribed, wholly novel products with important activities at target receptors.

Global Microbial Products Markets, Technology and Applications Report 2023: Market Trends 2019-2021, Estimates for 2022 and CAGR Projections through 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, November 13, 2023

The total global market for microbes and microbial products was worth $229.9 billion in 2021.

Key Points: 
  • The total global market for microbes and microbial products was worth $229.9 billion in 2021.
  • The 2022 market is projected to exceed $242.0 billion, and the 2027 market is expected to approach $346.3 billion.
  • A microbial product refers to any substance produced by microorganisms, such as bacteria, fungi, and algae, that has commercial value.
  • This report addresses the global market for microbes and microbial products used in commercial applications from 2021 through 2027.

NanoSyrinx appoints Anthony Johnson as Non-Executive Director

Retrieved on: 
Friday, November 10, 2023

NanoSyrinx, a synthetic biology company developing a novel platform for targeted intracellular delivery of biologic therapeutics, today announced Anthony Johnson, M. D., has joined its Board as Non-Executive Director.

Key Points: 
  • NanoSyrinx, a synthetic biology company developing a novel platform for targeted intracellular delivery of biologic therapeutics, today announced Anthony Johnson, M. D., has joined its Board as Non-Executive Director.
  • Tony’s appointment forms part of the Company’s ongoing strategy to expand and strengthen its leadership team as the Company prepares for the next stage in its development.
  • Most recently, Tony held the position of Chief Executive Officer at Goldfinch Bio and is Chair of the Board of Directors at Outrun Therapeutics.
  • Tony brings extensive and broad expertise to NanoSyrinx, particularly in drug discovery and early clinical development.

Marine Enzymes Market to increase by USD 54.62 million from 2023 to 2028, Advanced Enzyme Technologies Ltd., Air Liquide SA, Antozyme Biotech Pvt. Ltd., and more among key companies- Technavio

Retrieved on: 
Thursday, December 14, 2023

NEW YORK, Dec. 14, 2023 /PRNewswire/ -- The marine enzymes market is expected to grow by USD 54.62 million from 2023 to 2028.

Key Points: 
  • NEW YORK, Dec. 14, 2023 /PRNewswire/ -- The marine enzymes market is expected to grow by USD 54.62 million from 2023 to 2028.
  • Growing demand for food enzymes is notably driving the marine enzymes market.
  • However, factors such as the complex production process of marine enzymes may impede market growth.
  • We provide a detailed analysis of 20 companies operating in the marine enzymes market including Advanced Enzyme Technologies Ltd., Air Liquide SA, Antozyme Biotech Pvt.

One-Million-Followers-Strong Brand BE CHIC™ Hair Care Launches Texture Spray--Already Loved by A-Lister Sarah Paulson!

Retrieved on: 
Wednesday, December 13, 2023

Celebrity hairstylist launches Texture Spray, the first styling product from his plant-based hair care line BE CHIC™.

Key Points: 
  • Celebrity hairstylist launches Texture Spray, the first styling product from his plant-based hair care line BE CHIC™.
  • Part texturizer, part volumizer, light-to-medium-hold BE CHIC™ Texture Spray builds touchable texture at the roots or all over, giving every hair type and texture instant volume and gorgeous movement that lasts all day.
  • Formulated with clean, naturally nourishing ingredients, Texture Spray protects both hair and scalp while keeping strands exceptionally shiny—never dull or gritty.
  • Keeping nature-borne ingredients core to the brand, BE CHIC™ Texture Spray is formulated with clean, performance-driven ingredients, including:
    Amber Extract: Delivers nourishment to the scalp to promote healthy hair growth.

Synthetic biology market size to grow by USD 28.25 billion from 2022 to 2027, the evolving regulatory framework around synthetic biology is the market trend - Technavio

Retrieved on: 
Wednesday, December 13, 2023

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- The global synthetic biology market size is estimated to grow by USD 28.25 billion from 2022 to 2027, according to Technavio.

Key Points: 
  • NEW YORK, Dec. 12, 2023 /PRNewswire/ -- The global synthetic biology market size is estimated to grow by USD 28.25 billion from 2022 to 2027, according to Technavio.
  • The evolving regulatory framework around synthetic biology is a key trend in the market.
  • Therefore, the evolving regulatory framework for synthetic biology is expected to promote investments, foster innovation, and ensure the safety and efficacy of synthetic biology products, which, in turn, will support market growth during the forecast period.
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global synthetic biology market.

Ecovyst Announces Expansion and Rebranding of Advanced Silicas Product Portfolio

Retrieved on: 
Thursday, December 7, 2023

MALVERN, Pa., Dec. 7, 2023 /PRNewswire/ -- Ecovyst Inc. (the "Company"), a leading innovative and integrated global provider of advanced materials, specialty catalysts and services, announces a rebranding of its Advanced Silicas product portfolio.

Key Points: 
  • MALVERN, Pa., Dec. 7, 2023 /PRNewswire/ -- Ecovyst Inc. (the "Company"), a leading innovative and integrated global provider of advanced materials, specialty catalysts and services, announces a rebranding of its Advanced Silicas product portfolio.
  • The branding initiative highlights the expanding portfolio breadth, technology, and product development capability of Ecovyst that is focused on serving the evolving needs of its customers.
  • "The recent rebranding of our Advanced Silicas product portfolio underscores our ongoing commitment to technology leadership as we continue to innovate in close collaboration with our customers to deliver sustainable products and solutions."
  • For more information on Ecovyst and our Advanced Silicas portfolio, please visit us at www.ecovyst.com